Fulgent Genetics (FLGT) Depreciation & Amortization (CF) (2015 - 2026)

Fulgent Genetics has disclosed Depreciation & Amortization (CF) across 11 years of filings, most recently posting $7.7 million for Q2 2026.

• In Q2 2026, Depreciation & Amortization (CF) rose 26.79% year-over-year to $7.7 million; the TTM figure through Jun 2026 stood at $25.8 million (up 7.23% YoY), while the FY2025 annual figure was $24.1 million, down 3.23% from the prior year.
• Depreciation & Amortization (CF) came in at $7.7 million for Q2 2026 at Fulgent Genetics, up from $6.0 million in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $9.8 million in Q3 2022 to a low of $4.7 million in Q1 2022.
• Average Depreciation & Amortization (CF) over 5 years is $6.8 million, with a median of $6.3 million recorded in 2023.
• Year-over-year, Depreciation & Amortization (CF) soared 245.12% in 2022 and sank 34.63% in 2023.
• Over 5 years, Depreciation & Amortization (CF) stood at $9.8 million in 2022, then sank by 33.35% to $6.5 million in 2023, then fell by 5.22% to $6.2 million in 2024, then decreased by 1.29% to $6.1 million in 2025, then climbed by 25.59% to $7.7 million in 2026.
• Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $7.7 million in Q2 2026, $6.0 million in Q1 2026, and $6.1 million in Q4 2025.